Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study

Abstract

Background

Studies have shown significant associations of chronic kidney disease (CKD) and diabetes mellitus (DM) with cardiovascular disease (CVD) mortality. The impact on the general population is an important public health issue. However, the population attributable fraction (PAF) of CVD because of CKD and/or DM in a general population is uncertain.

Methods

We followed 7229 participants (age: ≥30 years) with no history of CVD in a Japanese community. We divided participants into four categories according to CKD and/or DM and calculated hazard ratios (HRs) of CVD mortality for each category using a Cox proportional hazards model adjusted for age, dyslipidemia, smoking and alcohol consumption. In addition, PAFs of CVD were estimated among populations with CKD and/or DM.

Results

During 20-year follow-up, 488 participants died. HRs for CVD were 1.63 [95% confidence interval (CI): 1.16–2.30] with DM only, 1.42 (95% CI: 1.08–1.86) with CKD only and 2.37 (95% CI: 1.40–4.01) with CKD + DM. In men, the corresponding HRs for CVD were 1.88 (95% CI: 1.19–2.97), 1.71 (95% CI: 1.15–2.56) and 3.26 (95% CI: 1.69–6.30), respectively; the corresponding PAFs of CVD were 4.1%, 5.1% and 2.9%, respectively. PAFs for CVD among women were lower than those in men, 1.6% for DM only, 2.0% for CKD only and 0.7% for CKD + DM.

Conclusions

PAFs of CVD mortality due to CKD and/or DM were not so high in past 20 years; however, they might increase in the future because of recent increase in prevalence of these in Japanese population.

Keywords

Cardiovascular disease chronic kidney disease diabetes mortality cohort studies general population population attributable fraction

Get full access to this article

View all access options for this article.

References

Shaw

Sicree

Zimmet

. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4–14.

Couser

Remuzzi

Mendis

. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258–1270.

Nakamura

Nakagawa

Murakami

. EPOCH–JAPAN research group: Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease. Kidney Int 2015; 88: 1144–1152.

Ohsawa

Fujioka

Ogasawara

. High risks of all-cause and cardiovascular deaths in apparently healthy middle-aged people with preserved glomerular filtration rate and albuminuria: A prospective cohort study. Int J Cardiol 2013; 170: 167–172.

Fox

Larson

Leip

. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844–850.

Nakamura

Okamura

Hayakawa

. NIPPON DATA90 Research Group: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 2006; 70: 954–959.

Weiner

Tighiouart

Amin

. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307–1315.

Ninomiya

Kiyohara

Kubo

. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228–236.

Fox

Matsushita

Woodward

. Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662–1673.

10.

Sugiyama

Okamura

Watanabe

. NIPPON DATA 80/90 Research Group: Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. J Atheroscler Thromb 2015; 22: 95–107.

11.

Hirata

Okamura

Sugiyama

. NIPPON DATA90 Research Group: The relationship between very high levels of serum high-density lipoprotein cholesterol and cause-specific mortality in a 20-year follow-up study of Japanese general population. J Atheroscler Thromb 2016; 23: 800–809.

12.

Inohara

Kohsaka

Okamura

. NIPPON DATA 80/90 Research Group: Cumulative impact of axial, structural, and repolarization ECG findings on long-term cardiovascular mortality among healthy individuals in Japan: National Integrated Project for Prospective Observation of Non-Communicable Disease and its Trends in the Aged, 1980 and 1990. Eur J Prev Cardiol 2014; 21: 1501–1508.

13.

Kashiwagi

Kasuga

Araki

. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 2012; 3: 39–40.

14.

Matsuo

Imai

Horio

. Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.

15.

Coresh

Astor

McQuillan

. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920–929.

16.

Imai

Horio

Watanabe

. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621–630.

17.

Matsushita

van der Velde

Astor

. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.

18.

Kogure

Tsuchiya

Hozawa

. Does the flushing response modify the relationship between alcohol intake and hypertension in the Japanese population? NIPPON DATA2010. Hypertens Res 2016; 39: 670–679.

19.

NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70: 1249–1255.

20.

Kadota

Miura

Okamura

. Carotid intima-media thickness and plaque in apparently healthy Japanese individuals with an estimated 10-year absolute risk of CAD death according to the Japan Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). J Atheroscler Thromb 2013; 20: 755–766.

21.

Cozzolino

Gentile

Mazzaferro

. Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis. Am J Kidney Dis 2013; 62: 984–992.

22.

Kramer

Saranathan

Luke

. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006; 17: 1453–1459.

23.

Ueshima

Choudhury

Okayama

. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 2004; 35: 1836–1841.

24.

Takashima

Ohkubo

Miura

. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens 2012; 30: 2299–2306.

25.

Zhang

Patel

Horibe

. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 2003; 32: 563–572.

26.

Ueshima

Sekikawa

Miura

. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008; 118: 2702–2709.

27.

Stone

Robinson

Lichtenstein

. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2889–2934.

28.

Okamura

Kokubo

Watanabe

. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study. Atherosclerosis 2011; 217: 201–206.

29.

Doi

Ninomiya

Hata

. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010; 41: 203–209.

30.

Saito

Folsom

Aono

. Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol 2000; 29: 837–884.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB